Fennec Pharmaceuticals Inc. (FRX.TO)

CAD 8.12

(-6.34%)

Revenue Summary of Fennec Pharmaceuticals Inc.

  • Fennec Pharmaceuticals Inc.'s latest annual revenue in 2023 was 21.25 Million USD , up 1284.5% from previous year.
  • Fennec Pharmaceuticals Inc.'s latest quarterly revenue in 2024 Q1 was 25.37 Million USD , up 160.68% from previous quarter.
  • Fennec Pharmaceuticals Inc. reported a annual revenue of 1.53 Million USD in annual revenue 2022, down 0.0% from previous year.
  • Fennec Pharmaceuticals Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Fennec Pharmaceuticals Inc. reported a quarterly revenue of 25.37 Million USD for 2024 Q1, up 160.68% from previous quarter.
  • Fennec Pharmaceuticals Inc. reported a quarterly revenue of 6.51 Million USD for 2023 Q3, up 95.94% from previous quarter.

Annual Revenue Chart of Fennec Pharmaceuticals Inc. (2023 - 1999)

Historical Annual Revenue of Fennec Pharmaceuticals Inc. (2023 - 1999)

Year Revenue Revenue Growth
2023 21.25 Million USD 1284.5%
2022 1.53 Million USD 0.0%
2021 - USD -100.0%
2020 170 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 0.66 USD -2.21%
1999 0.68 USD 0.0%

Peer Revenue Comparison of Fennec Pharmaceuticals Inc.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD -2468.506%
Eupraxia Pharmaceuticals Inc. - CAD -Infinity%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 16.51 Million CAD -28.685%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. - CAD -Infinity%
Oncolytics Biotech Inc. - CAD -Infinity%
Sernova Corp. - CAD -Infinity%